Financials
- Market Capitalization 452.96 M
- Employee 485
- Founded 2008
- CEO Jason Kelly
- Website www.ginkgobioworks.com
- Headquarter Delaware, United States
- FIGI BBG00YPS1KY3
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.98
売上高対価格比率
4.57
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2985 | GALT Galectin Therapeutics Inc. - Common Stock | 4.48 USD | +7.43% | +7.95% | +50.84% | +0.90% | 451.81 M USD | ||
| 2986 | OCGN Ocugen, Inc. - Common Stock | 1.32 USD | -0.75% | -7.04% | +6.45% | +30.69% | 447.63 M USD | ||
| 3006 | PRLD Prelude Therapeutics Incorporated - Common Stock | 5.43 USD | -1.09% | -13.12% | +16.77% | +384.82% | 433.33 M USD | ||
| 3007 | BNTC Benitec Biopharma Inc. - Common Stock | 12.88 USD | +4.63% | +1.02% | +8.51% | -22.46% | 442.48 M USD |